In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose
Zain Chagla
Abstract
SOURCE CITATION: N Engl J Med. 2021;384:403-16. 33378609.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pulmonology2019-20 coronavirus outbreakInternal medicineMEDLINEInfectious disease (medical specialty)DiseaseVirologyOutbreakPolitical scienceLawSARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesHepatitis B Virus Studies